title: Payers tightening management of specialty therapies.
abstract: Continued market growth among specialty therapies has attracted the attention of big pharma and investors. Many payers, however, believe the industry has reached a tipping point, where greater management focus - and tougher decisions - are needed.
authors.affiliation: is manager of syndicated research for The Zitter Group, in San Francisco.   is director of business content for The Zitter Group, in Milburn, N.J.
authors.forename: Kirk
authors.initials: K
authors.lastname: McConnell
authors.forename: Melinda C
authors.initials: MC
authors.lastname: Haren